Izraēla - ivrits - Ministry of Health

teva israel ltd - citalopram as hydrobromide - טבליות מצופות פילם - citalopram as hydrobromide 20 mg

Izraēla - ivrits - Ministry of Health

raz pharmaceutics ltd, israel - metoclopramide hydrochloride - תמיסה להזרקה - metoclopramide hydrochloride 5 mg/ml - metoclopramide

Izraēla - ivrits - Ministry of Health

david margalit & co.ltd - metoclopramide hydrochloride - תמיסה להזרקה - metoclopramide hydrochloride 5 mg/ml - metoclopramide

Izraēla - ivrits - Ministry of Health

unipharm ltd, israel - clomipramine hydrochloride - טבליה - clomipramine hydrochloride 25 mg - non selective monoamine reuptake inhibitors - depression of varying origin.in children and adolescents there is not sufficient evidence of safety and efficacy of maronil in the treatment of depressive states of varying aetiology and symptomatology. the use of maronil in children and adolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes.no experience is available in children younger than 5 years of age.

Izraēla - ivrits - Ministry of Health

megapharm ltd - hydrocortisone acetate; pramocaine hydrochloride - קצף - pramocaine hydrochloride 0.9363 %w/w; hydrocortisone acetate 0.9363 %w/w - relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - metoclopramide 5 mg - suppositories - metoclopramide - antiemetic and gi motility stimulation.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - metoclopramide 20 mg - suppositories - metoclopramide - antiemetic & gi motility stimulation in adults. treatment of symptomatic gi reflux oesophagitis that has not responded to conventional treatment.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 0.375 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 0.75 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 1.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.